Kenneth Ferguson
Director/Board Member chez CYCLACEL PHARMACEUTICALS, INC.
Profil
Kenneth M.
Ferguson is currently the Director at Cyclacel Pharmaceuticals, Inc. and an Operating Partner at Accelerator Services Corp.
Previously, he was the President, Chief Executive Officer & Director at Vactx International, Inc. from 2008 to 2010, COO, Chief Scientific Officer & Director at Lilly ICOS LLC, and President at ICOS Corp.
from 1990 to 2007.
He also served as the Chief Development Officer & Vice President at Omeros Corp.
from 2012 to 2017 and as the Chief Scientific Officer at EMulate Therapeutics, Inc. Dr. Ferguson received his undergraduate degree from Cornell University and his doctorate from Texas University of Health Center at San Antonio.
Postes actifs de Kenneth Ferguson
| Sociétés | Poste | Début |
|---|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Director/Board Member | 14/06/2022 |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Private Equity Investor | - |
Anciens postes connus de Kenneth Ferguson
| Sociétés | Poste | Fin |
|---|---|---|
| OMEROS CORPORATION | Corporate Officer/Principal | 01/05/2017 |
| Vactx International, Inc. | Chief Executive Officer | 01/11/2010 |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | President | 01/12/2007 |
EMulate Therapeutics, Inc.
 EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA. | Chief Tech/Sci/R&D Officer | - |
Lilly ICOS LLC
 Lilly ICOS LLC Pharmaceuticals: MajorHealth Technology Lilly ICOS LLC develops and markets medical drugs. It produces Cialis drug which is used for the treatment of erectile dysfunction. The firm's competitors are Viagra and Levitra. The company was founded in October 1998 and is headquartered in Indianapolis, IN. | Chief Tech/Sci/R&D Officer | - |
Formation de Kenneth Ferguson
| Cornell University | Undergraduate Degree |
| Texas University of Health Center at San Antonio | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| OMEROS CORPORATION | Health Technology |
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
Lilly ICOS LLC
Lilly ICOS LLC Pharmaceuticals: MajorHealth Technology Lilly ICOS LLC develops and markets medical drugs. It produces Cialis drug which is used for the treatment of erectile dysfunction. The firm's competitors are Viagra and Levitra. The company was founded in October 1998 and is headquartered in Indianapolis, IN. | Health Technology |
EMulate Therapeutics, Inc.
EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA. | Health Technology |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
| Vactx International, Inc. |
